BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

Mirus Bio LLC: Faster Biotherapeutic Protein Production With the New TransIT-PRO(TM) Transfection Kit


8/19/2010 8:27:01 AM

MADISON, Wis., Aug. 18 /PRNewswire/ -- Mirus Bio now offers a new transfection kit ideal for biotherapeutic protein production in large pharma and biotech settings. Mirus Bio's new TransIT-PRO Kit will decrease time to produce usable protein by maximizing target protein yields through transient transfection. TransIT-PRO Kit uses animal origin free components designed for high and reproducible protein yield in suspension CHO and 293 derived cells. Since it is compatible with varied media formulations, the same media can be used for both transient and stable expression. TransIT-PRO outperforms linear PEI in protein yield and reproducibility while providing a cost-effective alternative to FreeStyle MAX.

(Logo: http://photos.prnewswire.com/prnh/20100818/CG52502LOGO)

(Logo: http://www.newscom.com/cgi-bin/prnh/20100818/CG52502LOGO)

With TransIT-PRO you will:

  • Achieve high protein yield in suspension CHO and 293 cells
  • Experience compatibility with multiple CHO media formulations
  • Obtain reproducible protein expression with minimal optimization

Visit www.mirusbio.com for all your transfection needs including access to the citations database, data, protocols, technical support, inquiries about bulk pricing or to place an order.

The Transfection Experts

More than 15 years of gene delivery expertise.

Mirus pioneered scientific breakthroughs in non-viral gene delivery. These advancements established our products as industry leading transfection reagents. At Mirus, we continue to grow our expertise in nucleic acid delivery research and products to better serve you.

SOURCE Mirus Bio LLC


Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 

//-->